Who we are

kalacura-AI™ is a translational molecular diagnostics company developing investigational plasma-based molecular diagnostics in transplantation and oncology.

We are a multidisciplinary team of clinicians, scientists, and engineers integrating molecular biology, computational modelling, and clinical insight to advance high-resolution, non-invasive disease monitoring.

Our current programmes include sponsor-funded research and feasibility studies in transplant medicine, with parallel oncology investigations in development.

All assays and analyses are investigational and for research use only (RUO).